Robust response of pulmonary pleomorphic carcinoma to pembrolizumab and sequential radiotherapy: A case report-Reference-Cited by-同舟云学术

Robust response of pulmonary pleomorphic carcinoma to pembrolizumab and sequential radiotherapy: A case report

Published:2021-11-10 Issue:12 Volume:9 Page:
ISSN:2051-3380
Container-title:Respirology Case Reports
language:en
Short-container-title:Respirology Case Reports

Author:

Kim Tae‐Hun¹^ORCID,Park Sun Hyo¹^ORCID,Hwang Ilseon²^ORCID,Lee Jin Hee³^ORCID,Kim Jin Hee⁴^ORCID,Kim Hae Won⁵^ORCID,Kim Hyun Jung¹^ORCID

Affiliation:

1. Division of Pulmonary Disease and Critical Care Medicine, Department of Internal Medicine, Dongsan Hospital Keimyung University School of Medicine Daegu South Korea

2. Department of Pathology, Dongsan Hospital Keimyung University School of Medicine Daegu South Korea

3. Department of Radiology, Dongsan Hospital Keimyung University School of Medicine Daegu South Korea

4. Department of Radiation Oncology, Dongsan Hospital Keimyung University School of Medicine Daegu South Korea

5. Department of Nuclear Medicine, Dongsan Hospital Keimyung University School of Medicine Daegu South Korea

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rcr2.875

Reference22 articles.

1. Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma

2. Pleomorphic Carcinoma of the Lung

3. The 2015 World Health Organization Classification of Lung Tumors

4. Approaches to tumor classification in pulmonary sarcomatoid carcinoma;Baldovini C;Lung Cancer (Auckl),2019

5. Pleomorphic carcinoma of the lung: A surgical outcome

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Synergistic Interactions between Natural Compounds and Conventional Chemotherapeutic Drugs in Preclinical Models of Lung Cancer;Pharmaceuticals;2024-05-08